Quantitative Investment Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-13,721
Closed -$51K 601
2021
Q2
$51K Buy
+13,721
New +$47.7K ﹤0.01% 376
2020
Q3
Sell
-25,580
Closed -$86K 641
2020
Q2
$86K Sell
25,580
-124,719
-83% -$363K 0.01% 491
2020
Q1
$350K Buy
+150,299
New +$411K 0.04% 378
2019
Q4
Sell
-43,108
Closed -$357K 819
2019
Q3
$357K Buy
43,108
+4,766
+12% +$38.6K 0.02% 507
2019
Q2
$330K Buy
38,342
+8,642
+29% +$77.3K 0.01% 554
2019
Q1
$317K Buy
29,700
+4,000
+16% +$42.8K 0.02% 552
2018
Q4
$224K Buy
+25,700
New +$327K 0.01% 486
2018
Q3
Sell
-31,700
Closed -$664K 939
2018
Q2
$664K Buy
+31,700
New +$587K 0.01% 563
2016
Q3
Sell
-49,700
Closed -$326K 910
2016
Q2
$326K Buy
49,700
+28,500
+134% +$201K 0.02% 612
2016
Q1
$134K Buy
+21,200
New +$109K 0.01% 721

Other funds holding SPPI

Quantitative Investment Management's SPPI Position: Q3 2021 in Review

Quantitative Investment Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2021, closing a stake of 13,721 shares — an estimated $51K sold.

Quantitative Investment Management first reported a position in SPPI in Q1 2016 and held it in 10 quarters. The position peaked at $664K in Q2 2018. 147 funds tracked by Wall St. Rank hold SPPI as of Q3 2021.

  • Quantitative Investment Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 13,721 Spectrum Pharmaceuticals Inc shares in Q3 2021, an estimated $51K.
  • Quantitative Investment Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2016 and held it in 10 quarters.
  • Quantitative Investment Management's Spectrum Pharmaceuticals Inc position peaked at $664K in Q2 2018.
  • 147 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2021.

Based on Quantitative Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.